Alan Jardine
Professor
Department of Cardiovascular and Medical Sciences
University of Glasgow
United Kingdom
Biography
Alan Jardine is currently working as a Professor (Institute of Cardiovascular and Medical Sciences), Associate Academic (Institute of Infection Immunity and Inflammation)
Research Interest
Clinical pharmacology
Publications
-
Holdaas, H., Mjøen, G. and Jardine, A. G. (2017) Belatacept: where the BENEFITS outweigh the risk. American Journal of Kidney Diseases, 69(5), pp. 561-563. (doi:10.1053/j.ajkd.2017.02.007) (PMID:28434523)
-
Fellström, B. C. et al. (2017) Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. Lancet, 389(10084), pp. 2117-2127. (doi:10.1016/S0140-6736(17)30550-0) (PMID:28363480)
-
Rutherford, E., Stewart, G., Houston, J. G., Jardine, A. G. , Mark, P. B. and Struthers, A. D. (2017) An open-label dose-finding study of allopurinol to target defined reduction in urate levels in hemodialysis patients. Journal of Clinical Pharmacology, (doi:10.1002/jcph.939) (PMID:28597919)
